Form D · Biotechnology

Semma Therapeutics, Inc.

Cambridge, MA · CIK 0001637931

Offering snapshot reported Feb 26, 2019 · SEC filing

Reported sold
$114M
Offering amount: $120M
Investors reported
20
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 27, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$56.9M$114MDec 5, 2017: $53,860,712.00Dec 5, 2017Feb 26, 2019: $113,860,712.00Feb 26, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$53,860,712 → $113,860,712

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 26, 2019Amendment$113,860,712$60,000,000vs Dec 5, 201720SEC filing
Dec 5, 2017Initial$53,860,712No comparison20SEC filing
Mar 31, 2016Amendment$15,418,075$0vs Apr 1, 201510SEC filing
Apr 1, 2015Initial$15,418,075No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-300037
Series B Preferred Stock. Total amount sold includes $13,860,712 from note conversions.

Source: Form D, filed Feb 26, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Daniel Auerbach Director
Mitchell Finer Director
Mitch Finer Director
Mark Fishman Director
Todd Foley Director, Executive
Stephen Knight Director
Robert Millman Director, Executive
Kevin Raidy Director
William Sahlman Director
Bastiano Sanna Director, Executive
Jim Scopa Director
Elizabeth Stoner Executive
Kingsley Taft Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
450 Kendall Street Ste 2 B
Cambridge, MA, 02142